Healthcare Global Enterprises Ltd's Q3FY25 Quarterly Results

Result Summary

• Healthcare Global Enterprises Ltd reported a 0.3% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 18.3%.
• Its expenses for the quarter were up by 5.7% QoQ and 22.1% YoY.
• The net profit decreased 62.5% QoQ and increased 125.9% YoY.
• The earnings per share (EPS) of Healthcare Global Enterprises Ltd stood at 0.5 during Q3FY25.

Financial Statments for Q3FY25

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Healthcare Global Enterprises Ltd (HCG) is a leading provider in the healthcare sector, primarily focusing on cancer care and treatment. With a wide network of cancer centers across India, HCG offers comprehensive services including diagnosis, treatment, and post-treatment care. Known for its advanced technology and specialized expertise, the company also engages in research and development to continuously enhance its service offerings. While specific recent major developments are not provided, HCG is recognized for its contributions to expanding cancer care accessibility in India.

Revenue

In the third quarter of fiscal year 2025 (Q3FY25), Healthcare Global Enterprises Ltd reported a total income of ₹563.21 crores. This marks a slight decrease of 0.3% from the previous quarter (Q2FY25), where total income stood at ₹564.67 crores. However, there is a noticeable year-over-year increase of 18.3% compared to the same quarter in the previous fiscal year (Q3FY24), which recorded a total income of ₹475.94 crores. This year-over-year growth reflects a significant expansion in the company's revenue base, indicating increased service uptake or pricing adjustments over the year.

Profitability

The profitability metrics for Healthcare Global Enterprises Ltd in Q3FY25 show notable fluctuations. The company reported a Profit Before Tax (PBT) of -₹4.20 crores, a sharp decline from ₹27.68 crores in Q2FY25, representing a quarter-over-quarter decrease of 115.2%. Comparatively, the PBT in Q3FY24 was ₹11.07 crores, indicating a year-over-year decline of 137.9%. The Profit After Tax (PAT) for Q3FY25 was ₹7.75 crores, reflecting a decrease of 62.5% from Q2FY25's ₹20.68 crores but a substantial increase of 125.9% from ₹3.43 crores in Q3FY24. These figures underline significant variability in profitability due to changes in expenses or tax considerations. The Earnings Per Share (EPS) in Q3FY25 is ₹0.50, a decrease from ₹1.30 in Q2FY25 but an increase from ₹0.40 in Q3FY24, with changes of -61.5% QoQ and 25.0% YoY respectively.

Operating Metrics

Total expenses for Healthcare Global Enterprises Ltd in Q3FY25 were reported at ₹567.41 crores, which signifies a 5.7% increase from ₹536.99 crores in Q2FY25. Year-over-year, there is a 22.1% increase compared to ₹464.87 crores in Q3FY24. These rising expenses could be attributed to higher operational costs or investments in company infrastructure and services. The tax figure in Q3FY25 was -₹11.05 crores, contrasting with ₹6.97 crores in Q2FY25 and ₹7.63 crores in Q3FY24, showing significant reductions of 258.5% QoQ and 244.8% YoY. These tax metrics suggest adjustments in tax liabilities or benefits during the quarter. The financial data presents a complex picture of the company's operational activities and financial strategies over the recent quarters.